DideoxynucleosidesAnti-HIV AgentsReverse Transcriptase InhibitorsDrug HypersensitivityLamivudineZidovudineOrganophosphonatesOxazinesHIV InfectionsHLA-B AntigensBenzoxazinesAdenineHIV-1Antiretroviral Therapy, Highly ActiveDrug Therapy, CombinationHIV Reverse TranscriptaseViral LoadNevirapineHIV Protease InhibitorsArea Under CurveStandard of CareDrug Resistance, Multiple, ViralTreatment FailureRitonavirDeoxyguanine NucleotidesPharmacogeneticsLipodystrophySalmonella paratyphi ADibenzocycloheptenesIndinavirAnti-Retroviral AgentsDrug Dosage CalculationsCarbamatesPatch TestsCD4 Lymphocyte CountDrug Resistance, ViralBiomarkers, PharmacologicalCoagulantsHIV-Associated Lipodystrophy SyndromeStavudineDrug InteractionsAcridinesDidanosineIntention to Treat AnalysisLopinavirTabletsTetrahydroisoquinolinesDouble-Blind MethodTreatment OutcomeDeoxycytidineHIVDrug CombinationsChromatography, High Pressure LiquidGenetic TestingUgandaGenotypeAcquired Immunodeficiency SyndromePilot ProjectsAnti-Infective Agents, LocalDrug Administration ScheduleChemistry, PharmaceuticalSynaptophysinLeast-Squares AnalysisSulfonamidesMutationMajor Histocompatibility ComplexOligopeptidesPyridinesHalf-LifeCohort StudiesAdministration, OralRibavirinCross-Over StudiesPolyethylene Glycols